Incidence of Kidney Disease

New York Times  Mar 27  Comment 
Some older adults with advanced kidney failure are resisting the usual answer by deciding the sacrifices required by the treatment aren’t worth it.
NPR  Feb 12  Comment 
Tobacco's link to lung cancer, stroke and heart attack is well-known. But smokers are also more likely to die from kidney failure, infections and breast cancer, a revised tally suggests.
MedPage Today  Feb 6  Comment 
(MedPage Today) -- Photographer Ed Kashi sheds light on the epidemic of chronic kidney disease in Central America and why it's preventable.
NPR  Feb 4  Comment 
What's causing the ailment that has struck 20,000 farmhands in Nicaragua and El Salvador? Pesticides? Alcoholism? Rat pee spreading an infection? A study from Boston University provides some answers.
Motley Fool  Feb 3  Comment 
Ardelyx Inc. shares fell on news that its kidney disease drug resulted in a higher incidence of diarrhea than anticipated.
Benzinga  Dec 30  Comment 
NephroGenex, Inc. (Nasdaq: NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced the Company has successfully completed a thorough QT/QTc (TQT) cardiac safety study on Pyridorin. This...
NPR  Dec 18  Comment 
A new report looks at the top causes of death in 188 countries. Infectious diseases are less of a threat than in 1990 — but please, look both ways before you cross the street.
FierceBiotech  Dec 12  Comment 
A year after former partner GlaxoSmithKline closed the door on what could have been a $1.5 billion collaboration, Mountain View, CA's ChemoCentryx is touting a Phase II victory for its kidney disease treatment, news that promptly doubled its share...
Wall Street Journal  Dec 10  Comment 
DSI Renal, a company that provides dialysis care to patients with chronic kidney failure and renal disease, is on the auction block and could fetch about $1 billion including debt.
Benzinga  Dec 2  Comment 
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), a biopharmaceutical company focused on bringing innovative therapies to market for patients with renal disease, today announced the publication of Auryxia phase 2 clinical trial results in...

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki